- Generic name
- Ondansetron
- Strength
- 8 mg
- Dosage form
- Tablet
- Manufactured by
- Albion Laboratories Ltd.
Emofast 8 Tablet
About Emofast 8 Tablet
Emofast 8 is a tablet from Albion Laboratories Ltd., with the generic name Ondansetron. It is not a general stomach medicine, so a doctor should confirm whether it fits the person's situation.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Emofast 8 Tablet?
Made by Albion Laboratories Ltd., Emofast 8 is a tablet whose active ingredient is Ondansetron. It is prescribed to help prevent and treat nausea and vomiting that can follow cancer chemotherapy, radiotherapy, or an operation. It does not treat the underlying cause of vomiting. The doctor decides the dose and course for each person.
Uses of Emofast 8
It is not a general stomach medicine, so a doctor should confirm whether it fits the person's situation. Only a doctor can decide whether it is suitable for a particular person. Emofast 8 is used to help prevent and treat nausea and vomiting in particular medical situations. Always follow the doctor's advice regarding its use.
How to use Emofast 8
The dose, how often it is taken and how long the course lasts are all decided by the doctor, so follow the instructions given to you. Swallow the tablet with water. Emofast 8 is taken by mouth. If you are unsure how to take it, ask your doctor or pharmacist. The doctor decides the dose and the course, including how it fits around chemotherapy, radiotherapy or surgery. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Emofast 8
A feeling of flushing or warmth and hiccups have also been reported, along with liver enzyme abnormalities. Common side effects include headache, constipation, and diarrhea. Rarely, serious allergic reactions, breathing problems, or chest pain may occur. Tell your doctor if you notice any side effect that bothers you or does not go away.
Safety and precautions
It should not be used instead of nasogastric suction. People with liver problems or other illnesses should ask the doctor before use. There are no adequate, well-controlled studies in pregnant women, so ask your doctor before use if you are pregnant, planning pregnancy or breastfeeding. Tell your doctor before using Emofast 8 8 mg tablet if you are allergic to Ondansetron or any of its ingredients, or if you have had reactions to other similar anti-emetic medicines.
Frequently asked questions
What is Emofast 8 used for?
It is not a general stomach medicine, so a doctor should confirm whether it fits the person's situation. Only a doctor can decide whether it is suitable for a particular person.
How do I use Emofast 8 correctly?
The dose, how often it is taken and how long the course lasts are all decided by the doctor, so follow the instructions given to you. Swallow the tablet with water.
Can Emofast 8 cause side effects?
A feeling of flushing or warmth and hiccups have also been reported, along with liver enzyme abnormalities. Common side effects include headache, constipation, and diarrhea.
Who should be careful with Emofast 8?
It should not be used instead of nasogastric suction. People with liver problems or other illnesses should ask the doctor before use.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.